These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21482398)

  • 1. [Immunosuppression in kidney transplantation].
    Balssa L; Bittard H; Kleinclauss F;
    Prog Urol; 2011 Apr; 21(4):250-3. PubMed ID: 21482398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CARI guidelines. Calcineurin inhibitors in renal transplantation: the addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients.
    Webster AC;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S75-84. PubMed ID: 17316285
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression on the horizon.
    Eisen HJ
    Heart Fail Clin; 2007 Jan; 3(1):43-9. PubMed ID: 17545008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antibody induction in pediatric renal transplantation.
    Pescovitz MD
    Curr Opin Organ Transplant; 2008 Oct; 13(5):495-9. PubMed ID: 19060532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
    Hardinger KL
    Pharmacotherapy; 2006 Dec; 26(12):1771-83. PubMed ID: 17125438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation in adolescents.
    Smith JM; McDonald RA
    Adolesc Med Clin; 2005 Feb; 16(1):201-14. PubMed ID: 15844392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced exposure to calcineurin inhibitors in renal transplantation.
    Guba M; Jauch KW
    N Engl J Med; 2008 Jun; 358(23):2518; author reply 2519-20. PubMed ID: 18525054
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation.
    Mandelbrot D
    J Am Soc Nephrol; 2009 Jun; 20(6):1170-1. PubMed ID: 19470672
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological treatment following renal transplantation].
    Viklický O
    Vnitr Lek; 2011; 57(7-8):650-3. PubMed ID: 21877601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression without calcineurin inhibition: by ZEUS.
    Flechner SM
    Lancet; 2011 Mar; 377(9768):788-9. PubMed ID: 21334739
    [No Abstract]   [Full Text] [Related]  

  • 11. Alemtuzumab in kidney-transplant recipients.
    Markmann JF; Fishman JA
    N Engl J Med; 2011 May; 364(20):1968-9. PubMed ID: 21591949
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
    Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transplantation strategies in immunized and hyperimmunized patients].
    Antoine C
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S174-8. PubMed ID: 19000882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of induction therapy in kidney transplantation.
    Hardinger KL; Brennan DC; Klein CL
    Transpl Int; 2013 Jul; 26(7):662-72. PubMed ID: 23279211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies in renal transplantation].
    Bonvoisin C; Weekers L; Grosch S; Krzesinski JM
    Rev Med Liege; 2009; 64(5-6):287-92. PubMed ID: 19642461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The new immunosuppressive drugs for renal transplantation: inhibitors of the mammalian target of rapamycin (mTOR) and anti-thymocyte globulin (Thymoglobulin)].
    Nakagawa Y; Ikeda M; Tasaki M; Saito K; Takahashi K
    Nihon Jinzo Gakkai Shi; 2013; 55(2):112-8. PubMed ID: 23631297
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of immunosuppressive agents for solid organ transplantation in children.
    Coelho T; Tredger M; Dhawan A
    Pediatr Transplant; 2012 Mar; 16(2):106-22. PubMed ID: 22360399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithymocyte globulin versus basiliximab in renal transplantation.
    Killen JP; Chadban S
    N Engl J Med; 2007 Feb; 356(6):634; author reply 634-5. PubMed ID: 17287486
    [No Abstract]   [Full Text] [Related]  

  • 19. [Daclizumab and basiliximab: monoclonal mouse-man antibodies with effective immunosuppression without side effects].
    ter Meulen CG; Hilbrands LB; van Riemsdijk-van Overbeeke IC; Hené RJ; Christiaans MH; Hoitsma AJ
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2396-400. PubMed ID: 11145094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin-2 receptor blockers in renal transplantation].
    Basić-Jukić N; Bubić-Filipi L; Danić A; Pasini J; Kes P
    Acta Med Croatica; 2004; 58(5):395-9. PubMed ID: 15756806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.